Immuno-Biological Laboratories Co., Ltd.

Research Immuno-Biological Laboratories Co., Ltd. (4570.T) on Bullrun: market cap JPY 9.79B, P/E 26.6, dividend yield 0.6%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker4570.T
ExchangeTSE
CountryJapan
SectorHealthcare
IndustryBiotechnology
CurrencyJPY
Market capJPY 9.79B
P/E26.6
Dividend yield0.6%
Financial periodFY2026
RevenueJPY 1.00B
Revenue growth3.7%
Net incomeJPY 329.02M
Free cash flowJPY 267.68M
Gross margin70.4%

Valuation Snapshot

latest market cap is JPY 9.79B; P/E is 26.6; dividend yield is 0.6%.

Peer valuation comparison

Latest P/E is 26.57x versus a Healthcare sector median of 21.8x (21.9% above).

Latest dividend yield is 0.6% versus a Healthcare sector median of 2.41% (75.1% below).

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2026	JPY 1.00B	JPY 329.02M	JPY 267.68M	70.4%	35.33	JPY 989.47M	JPY 177.09M	JPY 1.84B
FY2025	JPY 969.53M	JPY 249.05M	JPY 123.84M	65.4%	26.74	JPY 825.73M	JPY 204.23M	JPY 1.51B
FY2024	JPY 816.70M	JPY 186.69M	JPY 115.12M	63.3%	20.05	JPY 734.14M	JPY 235.98M	JPY 1.27B
FY2023	JPY 794.62M	-JPY 289.73M	JPY 26.46M	66.3%	-31.1	JPY 614.16M	JPY 234.99M	JPY 1.08B

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	JPY 9.79B	26.6	0.7%	7.5

Dividend history

Latest trailing dividend snapshot: annual dividend/share 7.5 JPY, yield 0.6%.

Year	Dividends/share
FY2026	6 JPY

About Immuno-Biological Laboratories Co., Ltd.

Immuno-Biological Laboratories Co., Ltd. engages in the research, development, manufacturing, and supply of various immunological research reagents internationally. The company offers ELILSA, an assay kit to quantitatively measure targeted substances;

Related stock research

Japan stocks Japan Healthcare stocks A-Z stock index

Other Healthcare stocks

Veritas In Silico Inc. (130A.T) Kohjin Bio Co., Ltd. (177A.T) Chordia Therapeutics Inc. (190A.T) PRISM BioLab Co.,LTD (206A.T) GNI Group Ltd. (2160.T) Linical Co., Ltd. (2183.T) Heartseed Inc. (219A.T) Transgenic Group Inc. (2342.T) Soiken Holdings Inc. (2385.T) ADR Biomedical Holdings Inc. (3750.T) AnGes, Inc. (4563.T) OncoTherapy Science, Inc. (4564.T)

Frequently asked questions

What is Immuno-Biological Laboratories Co., Ltd.'s market cap?

Immuno-Biological Laboratories Co., Ltd.'s market capitalization is JPY 9.79B.

What is Immuno-Biological Laboratories Co., Ltd.'s P/E ratio?

Immuno-Biological Laboratories Co., Ltd.'s price-to-earnings (P/E) ratio is 26.6.

Does Immuno-Biological Laboratories Co., Ltd. pay a dividend?

Immuno-Biological Laboratories Co., Ltd. has a dividend yield of 0.6%.

What does Immuno-Biological Laboratories Co., Ltd. do?

Immuno-Biological Laboratories Co., Ltd. engages in the research, development, manufacturing, and supply of various immunological research reagents internationally.